Anna N A Tosteson
Overview
Explore the profile of Anna N A Tosteson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
7123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moen E, Wang Q, Liu L, Wang F, Tosteson A, Smith R, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2461021.
PMID: 39982726
Importance: Patients often travel for cancer care, yet the extent to which patients cross state lines for cancer care is not well understood. This knowledge can have implications for policies...
2.
Lawson M, Zhu W, Miglioretti D, Onega T, Henderson L, Rauscher G, et al.
Radiology
. 2025 Feb;
314(2):e241673.
PMID: 39964269
Background Diagnostic imaging and biopsy are used to evaluate abnormal screening mammography. Differences in on-site availability and receipt of these diagnostic services may contribute to disparities in breast cancer outcomes...
3.
Cornelius S, Schaefer A, Tosteson A, OMalley A, Wong S, Moen E
Med Care
. 2024 Dec;
63(1):62-69.
PMID: 39642017
Objective: Physician turnover rates are rising in the United States. The cancer workforce, which relies heavily on clinical teamwork and care coordination, may be more greatly impacted by turnover. In...
4.
Foster V, Trentham-Dietz A, Stout N, Lee C, Ichikawa L, Eavey J, et al.
J Natl Cancer Inst
. 2024 Oct;
PMID: 39475439
The extent and determinants of supplemental screening among women with dense breasts are unclear. We evaluated a retrospective cohort of 498,855 women aged 40-74 years with heterogeneously or extremely dense...
5.
Atlas S, Gallagher K, McGovern S, Wint A, Smith R, Aman D, et al.
J Gen Intern Med
. 2024 Oct;
PMID: 39424768
Background: Timely follow-up after an abnormal cancer screening test result is needed to maximize the benefits of screening, but is frequently not achieved. Little is known about patient experiences with...
6.
Onega T, Ramkumar N, Brooks G, Loehrer A, Kapadia N, OMalley A, et al.
J Rural Health
. 2024 Oct;
PMID: 39394970
Purpose: We examined the relationship between travel burden for surgical cancer care and rurality, geographic bypass of the nearest surgical facility, cancer type, and mortality outcomes. Methods: Using Medicare claims...
7.
Gunn C, Kressin N, Battaglia T, Schonberg M, Paasche-Orlow M, Tosteson A
J Gen Intern Med
. 2024 Sep;
39(16):3360-3362.
PMID: 39261341
No abstract available.
8.
Miglioretti D, Abraham L, Sprague B, Lee C, Bissell M, Ho T, et al.
Ann Intern Med
. 2024 Sep;
177(10):1297-1307.
PMID: 39222505
Background: False-positive results on screening mammography may affect women's willingness to return for future screening. Objective: To evaluate the association between screening mammography results and the probability of subsequent screening....
9.
Stout N, Miglioretti D, Su Y, Lee C, Abraham L, Alagoz O, et al.
JAMA Intern Med
. 2024 Aug;
184(10):1222-1231.
PMID: 39186304
Importance: Information on long-term benefits and harms of screening with digital breast tomosynthesis (DBT) with or without supplemental breast magnetic resonance imaging (MRI) is needed for clinical and policy discussions,...
10.
Relative Timing of Mammography and MRI for Breast Cancer Screening: Impact on Performance Evaluation
Lee J, Ichikawa L, Kerlikowske K, Buist D, Lee C, Sprague B, et al.
J Am Coll Radiol
. 2024 Jul;
21(11):1722-1732.
PMID: 38969253
Objective: Mammography and MRI screening typically occur in combination or in alternating sequence. We compared multimodality screening performance accounting for the relative timing of mammography and MRI and overlapping follow-up...